NOVEL HETEROARYL COMPOUND, ENANTIOMER, DIASTEREOMER OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND ANTIVIRAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT
申请人:INSTITUT PASTEUR KOREA
公开号:US20200031816A1
公开(公告)日:2020-01-30
The present invention relates to a novel heteroaryl compound, an enantiomer, a diastereomer or a pharmaceutically acceptable salt thereof, and an antiviral composition comprising the same as an active ingredient. The novel compounds represented by formula (I) or formula (II) according to the present invention are remarkably superior in antiviral activity against an influenza virus, and furthermore, have low cytotoxicity and thus low adverse effects on a human body. Therefore, a pharmaceutical composition containing the same as an active ingredient can be effectively used for the prevention or treatment of diseases caused by an influenza virus infection.
本发明涉及一种新型杂环芳基化合物,其对映异构体、顺异构体或其药学上可接受的盐,以及包含其作为活性成分的抗病毒组合物。根据本发明的化合物代表的新型化合物(I)或化合物(II)在抗流感病毒活性方面明显优越,并且具有低细胞毒性,因此对人体的不良影响较低。因此,含有该化合物作为活性成分的药物组合物可有效用于预防或治疗由流感病毒感染引起的疾病。